Navigation Links
AAO-SOE Joint Meeting Nov. 9 glaucoma research highlights
Date:11/8/2008

ATLANTA Glaucoma-related highlights of today's scientific program of the 2008 Joint Meeting of the American Academy of Ophthalmology (Academy) and European Society of Ophthalmology (SOE) include a study that correlates optic nerve damage in glaucoma patients with carotid artery narrowing and potentially elevated risk for stroke, and a survey that looks at how the practice of fasting, common to the world's seven major religions, may affect patient compliance with treatment for glaucoma and other eye diseases.

Damage to Optic Nerve in Glaucoma Patients May Indicate Significant Carotid Artery Narrowing

Glaucoma is often associated with elevated pressure inside the eye (intraocular pressure, or IOP) which can damage the optic nerve, leading to vision loss and even blindness. Medication and/or surgery allow patients to control their IOP, thus preventing the development of vision loss. Mostafa Elgohary, MD, of Essex County and Broomfield Hospitals in the UK and his colleagues were concerned when several patients who had been under their care for several years continued to lose their vision in one or both eyes even though their IOP had been kept within normal limits either through medicine or surgery.

The authors reviewed 16 retrospective case reports to determine if there was a possible association of internal carotid artery narrowing, or stenosis, with the development of glaucoma or glaucoma-like damage to the optic nerve. The internal carotid arteries are the main arteries in the neck that carry the blood to the brain and the eye. On further investigation, the authors found that six of those patients had significant carotid artery narrowing (greater than 60 percent of the artery lumen) and some even had total blockage of the artery on the same side as the eye with the glaucoma, or on both sides. One patient showed improvement in the visual field after undergoing surgery to remove the blockage. The authors then extended their inv
'/>"/>

Contact: Mary Wade
mwade@aao.org
415-531-3061
American Academy of Ophthalmology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. AAO-SOE Joint Meeting research highlights
2. Wait time guarantees not likely to reduce waits for joint replacement surgery
3. Successive Births, HRT Use Boost Joint Replacement Risks
4. Norma Smith and Dr. Steven A. Stuchin honored at 2008 Founders Gala for NYU Hospital for Joint Diseases
5. New Joint Commission Consulting Service by NurseTesting Grows Fast as Staffing Agencies Seek Joint Commission Certification
6. Stuart Chesky, DO, JD, Ohio KePRO Medical Director, Appointed to Ohio Joint Legislative Study Commission on Most Favored Nation Clauses in Health Care Contracts
7. KidsPeace Awarded Gold Seal of Approval by Joint Commission
8. www.Joyn7030.com, A New Web Site Dedicated to Helping Women Fight Joint Pain, Launches
9. XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market
10. Facet joint effusion and interspinal ligament edema: major sources of lower back pain
11. Battelle and YuYu Pharma Create the First Joint Bioequivalence Test Experimentation Institution
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8 2009 12410 1Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8 2009 12410 2Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8 2009 12410 3Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8 2009 12410 4Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 1Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 2Free Manicures 26 Martinis Hits San Francisco and Laguna Niguel 47586 3Solta Medical Inc to Present at 8th Annual Needham Life Sciences Conference 47584 1Solta Medical Inc to Present at 8th Annual Needham Life Sciences Conference 47584 2